Trials / Completed
CompletedNCT02692664
Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm With the Branched E-liac Stent Graft
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 71 (actual)
- Sponsor
- JOTEC GmbH · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
In this study, patients will be observed who receive an E-liac Stent Graft for treatment of isolated iliac aneurysms or an E-liac Stent Graft in combination with one of the following AAA stent grafts: E-tegra Stent Graft, Endurant AAA Stent Graft, Zenith AAA Endovascular Graft, Gore Excluder AAA Endoprosthesis for treatment of aorto-iliac aneurysms. Objectives of this post-market registry are: Primary: To prevent the risk of rupture and death by the treatment of common iliac aneurysm with an iliac branched stent graft (E-liac, JOTEC) Secondary: Evaluation of safety and feasibility of the E-liac Stent Graft System used in endovascular treatment of uni- or bilateral aorto-iliac or iliac aneurysm.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Endovascular aorto-iliac repair |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2024-07-05
- Completion
- 2024-07-05
- First posted
- 2016-02-26
- Last updated
- 2026-02-17
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02692664. Inclusion in this directory is not an endorsement.